R&D Tax Credits & Incentives Around The World: A Global Guide

Find out how R&D tax incentives compare across the world, including in the United States, Europe, Canada, China, Australia & more.

Research and development tax incentives have become one of the most important, and most misunderstood, tools that governments use to support innovation in their economies. Once a niche feature of tax policy, they are now central to national industrial strategies, start-up funding models, and investment decisions.

Across the OECD and beyond, governments are competing to attract and retain innovative businesses by reducing the costs of R&D. Some do this through generous tax credits, others through super-deductions, cash refunds, or direct grants. The result is a complex global landscape, where headline rates alone rarely tell the full story.

This guide provides a clear, accurate comparison of major R&D tax incentive schemes worldwide. It explains how different incentives work, where they are most valuable in practice, and how the UK’s approach compares internationally.

Types of R&D Incentive

Governments can support research and development in different ways, but most incentives fall into four broad models. Understanding how each one works, and what it means for your business’ cashflow, eligibility, and compliance is essential for understanding R&D incentives around the world.

1. Tax Credits

Tax credits directly reduce corporate tax liability. They are the most visible form of R&D support and are widely used by scale-ups and established businesses.

Credits can be structured in different ways:

• Volume-based credits, which apply to all qualifying R&D spend.
  
• Incremental credits, which only apply to increased R&D spend above a historical baseline. For instance, under the US ASC credit system, if a company’s ‘baseline R&D spend’ is $1m and it spends $1.3m in 2026, only the incremental $300k qualifies for a credit.

Examples of tax credit schemes include the UK’s merged R&D Expenditure Credit, the US federal R&D credit, and France’s Crédit d’Impôt Recherche.

Tax credits are most valuable to companies that are already profitable or close to profitability, as they reduce the corporation tax liability rather than generating cash directly.

2. Deductions and super-deductions

Deductions reduce taxable profits. Super-deductions go further, allowing companies to deduct more than they actually spend on R&D. This approach is common in countries with a strong focus on manufacturing, hardware, and industrial technology.

For instance, under a super-deduction regime with a 200% rate, a company spending ¥1m on R&D can deduct ¥2m from their taxable income.

Examples of this include China’s 200–220% super-deduction and Brazil’s Lei do Bem, which allows deductions of up to 180% of qualifying R&D expenditure.

These super-deduction incentives primarily benefit profitable companies. Loss-making businesses will only realise value once they generate taxable income in future years. For governments, super-deductions are an efficient way to encourage industrial R&D without issuing cash refunds.

3. Refundable credits and cash offsets

Refundable incentives convert R&D spending into direct cash, which is especially valuable for companies that are loss-making or only marginally profitable. This model is particularly important in sectors with long development cycles, such as deep tech, life sciences, and climate technology.

If a business has little or no corporation tax to pay, the credit is either paid out as a cash refund or offset against payroll taxes.

Examples include:

• Canada’s refundable SR&ED credits for CCPCs
  
• Australia’s refundable R&D offset for smaller companies
  
• The US payroll tax offset for early-stage startups
  
• The UK’s ERIS pathway, which provides an effective cash benefit of up to ~27% of qualifying R&D spend for loss-making, R&D-intensive SMEs, via a 14.5% payable credit on an enhanced loss base
  

Refundability often determines whether an incentive is genuinely useful in practice, particularly for early-stage and venture-backed companies.

4. Grants and targeted funding

Grants remain a core part of R&D policy in countries that use industrial strategy to steer innovation. Unlike tax incentives, grants can be targeted at specific technologies, sectors, or national priorities.

Companies typically apply for matched funding or project-specific support. Some grants are repayable through royalties if the project commercialises successfully.

Examples include Israel Innovation Authority grants, Innovate UK funding, Horizon Europe, and Japan’s collaborative R&D programmes.

Grants are particularly valuable for early-stage scientific research, capital-intensive R&D, and collaborative projects.

What shapes the real value of an incentive?

Headline rates can be misleading. In practice, three factors define how useful an R&D incentive will be:

1. Refundability – critical for loss-making and early-stage companies
2. Complexity and compliance burden – documentation requirements vary significantly by country
3. How R&D is defined and enforced – strict definitions reduce risk but increase effort

Understanding these trade-offs is as important as comparing percentages.

R&D Incentives: By Country

Navigating the global landscape of R&D incentives can be confusing. To help you compare “apples to apples,” we have broken down the major schemes below.

We have included a “Cheat Sheet” table for a quick overview, followed by a detailed look at each key region.

Country	Primary Model	Standard Benefit Rate	Refundable (Cash)?	Key Feature
🇬🇧 UK	Expenditure Credit	20% (Net ~15-16%)	✅ Yes	Merged Scheme: Unified rules for most companies.
🇺🇸 USA	Tax Credit	~6% – 10% (Effective)	❌ No*	* Cash allowed only for startups (<5 yrs old) against payroll tax.
🇨🇦 Canada	Tax Credit	15% – 35%	✅ Yes	Generous refundable rates for Canadian private corps.
🇫🇷 France	Tax Credit	30%	✅ Yes	Volume-based: Applies to total spend, not just growth.
🇮🇪 Ireland	Tax Credit	30% (35% from 2026)	✅ Yes	Cash refunds paid out in installments.
🇨🇳 China	Super-deduction	200% deduction	❌ No	Reduces taxable profit rather than the tax bill directly.

1. United Kingdom 

As of April 2024, the UK has moved to a simplified setup. 

• The Scheme: Most companies now use the Merged R&D Expenditure Credit (RDEC).
• The Benefit: You get a flat 20% credit on your R&D spend. However, this credit is taxable, meaning the net cash benefit is roughly 15% – 16.2% (depending on your tax rate).
• For Loss-Making SMEs: There is a special pathway called ERIS (Enhanced R&D Intensive Support). If you are loss-making and spend 30%+ of your expenses on R&D, you can access a higher benefit of up to 27% of your qualifying spend.

Important Deadline: New claimants must submit a Claim Notification Form to HMRC within 6 months of the end of the accounting year. Missing this invalidates your claim. See UK R&D tax claim deadlines.

2. United States 

The US system is famously complex. While the headline numbers look similar to the UK, the actual cash value is often lower..

• The Headline Rates:
  • Regular Credit: 20% rate.
  • Alternative Simplified Credit (ASC): 14% rate.
• The Catch:
  Unlike the UK (which pays out on your total R&D bill), the US system is typically incremental. It mostly rewards you for increasing your spend year-over-year. As a result, the effective cash benefit usually lands between 6% – 10% of your total R&D spend.
• For Startups: If you are a startup (under 5 years old with <$5m revenue), you can use the credit to offset up to $500,000 of payroll taxes. This is a crucial lifeline for pre-revenue companies.

3. Canada (SR&ED)

Canada’s SR&ED (Scientific Research and Experimental Development) program is one of the most generous in the world for smaller companies, but it is strict on definitions.

• Benefit for Canadian Private Corps (CCPCs): A massive 35% refundable credit on the first CAD 3 million of spend. This means for every $100 spent, the government writes a check for $35.
• Benefit for Others: A 15% non-refundable credit (used to reduce tax bills).

4. France (Crédit d’Impôt Recherche)

France is a powerhouse for large R&D hubs. The Crédit d’impôt recherche (CIR) programme aims to support this, with a 30% tax credit on eligible R&D spend.

• The Benefit: A 30% tax credit on spend up to €100m.
• Why it’s popular: It is volume-based (like the UK), meaning you get the 30% on your entire R&D budget, not just the increase. This makes it very attractive for large, stable engineering teams.

5. Ireland

Ireland is a favorite for US multinationals.

• The Benefit: A 30% refundable credit (rising to 35% in Jan 2026).
• How it pays: The refund is paid out over three years. It is “above the line,” meaning it boosts a company’s pre-tax earnings report, which CFOs love.

6. Netherlands (WBSO)

• The Mechanism: Instead of a corporation tax credit, the Netherlands offers a Wage Tax Reduction.
• The Benefit: You simply pay less payroll tax for your R&D staff. The rate is 36% (or 50% for startups) on the first €380k of wage costs.
• Process: Uniquely, you must apply in advance to the government agency (RVO) before doing the work.

7. China

• The Mechanism: A Super-deduction.
• How it works: If you spend ¥1m, you deduct ¥2m from your taxable income.
• The Result: It creates a huge tax shield for profitable manufacturers, but offers zero cash to loss-making startups.

8. Australia

• The Benefit:
  • Small Companies (<$20m turnover): A refundable offset of 18.5% above your corporate tax rate (Total value ~43.5%).
  • Large Companies: A non-refundable offset based on “R&D Intensity” (how much of your total budget goes to R&D).

Summary

R&D tax incentives are no longer a niche tax relief. They are a central part of how countries compete for innovation, capital, and talent. But generosity on paper does not always translate into value in practice.

For companies operating internationally, or companies that are planning to scale, it’s essential to understand the structure, refundability, and compliance expectations of each scheme.Done well, R&D incentives can materially extend runway, de-risk innovation, and support long-term growth. Done poorly, they can introduce unnecessary risk.

As with any complex tax relief, accuracy, documentation, and compliance matter as much as ambition.